Telephone Consultation for Menopausal Blood Test Results
Yes, you can absolutely discuss your blood test results and medication management with your doctor over the phone—this is an appropriate and efficient way to review results and adjust your current estrogen patch therapy, especially since you're already established on treatment.
Why Phone Consultation is Appropriate
For a 53-year-old woman already on menopausal hormone therapy (MHT) with estrogen patches, a telephone consultation is perfectly suitable for:
- Reviewing blood test results (though routine hormone level monitoring is generally not recommended for symptom management) 1
- Assessing symptom control and whether your current patch dose is adequate
- Discussing any side effects or concerns with your current regimen
- Adjusting dosing if needed based on your clinical response
What Your Doctor Will Likely Focus On
Current Treatment Assessment
Your doctor will evaluate whether your estrogen patches are providing adequate symptom relief. The goal is to use the lowest effective dose that controls your vasomotor symptoms, with upward titration based on clinical response rather than blood hormone levels 1.
Important Context for Your Situation
At 53 years old and within the appropriate treatment window, you fall into the favorable benefit-risk category for MHT. For women under 60 or within 10 years of menopause onset with no contraindications, the benefit-risk ratio strongly favors hormone therapy for bothersome symptoms 2, 3.
Key Points Your Doctor Should Address
Transdermal estrogen (patches) is an excellent choice for you because:
- It avoids first-pass hepatic metabolism, reducing risks of blood clots compared to oral estrogen 1, 4
- It's particularly preferable if you have any cardiovascular risk factors, hypertension, obesity, or diabetes 1
- It can be easily adjusted to your individual needs 1
What Blood Tests Actually Mean for Menopause Management
A critical caveat: Clinicians typically do not measure estradiol levels to monitor MHT except when symptoms don't improve with escalating doses, particularly after changing from oral to transdermal administration 1. Your symptoms—not blood levels—should guide treatment decisions.
If your doctor ordered blood tests, they were likely checking:
- Thyroid function (symptoms can mimic menopause)
- General health markers
- Ruling out other conditions
Medication Management Discussion Points
If Symptoms Are Not Controlled
If your patches aren't adequately controlling symptoms, your doctor can:
- Increase the patch dose (starting doses are typically lower than research trial doses, with room for upward adjustment) 1
- Consider switching formulations or delivery methods
- Ensure you have appropriate progestogen protection if you still have your uterus 2
If You Have Side Effects or Contraindications
Second-line options include serotonin-norepinephrine reuptake inhibitors like desvenlafaxine or venlafaxine (moderate-certainty evidence) 2.
Third-line alternatives include selective serotonin reuptake inhibitors, gabapentin, or newer neurokinin receptor antagonists (fezolinetant or elinzanetant) 2.
Shared Decision-Making Approach
Your consultation should use a shared decision-making framework that considers your individual situation, risks, treatment goals, values, preferences, and access to treatments 1, 2. This is particularly important for ongoing management and any dose adjustments.
Periodic Reevaluation
Since you've been on treatment for a couple of years, this is an appropriate time to reassess:
- Whether you still need treatment (persistent symptoms warrant continuation) 3
- Current dose adequacy
- Any new risk factors that have emerged
- Your satisfaction with treatment and quality of life
Common Pitfalls to Avoid
- Don't stop treatment abruptly without medical guidance—symptoms often return
- Don't assume blood hormone levels dictate dosing—your symptom relief is the primary endpoint
- Don't delay the conversation—uncontrolled menopausal symptoms significantly impact quality of life, which is a priority outcome
The phone consultation is entirely appropriate for this follow-up discussion, and your doctor can make informed decisions about your ongoing management based on your symptom response and any relevant test results 5.